01:39 AM EDT, 07/31/2026 (MT Newswires) -- Medacta Group (MOVE.SW) said Friday that its preliminary revenue for the first half increased year over year. The Swiss orthopedic products company's revenue for the six months ended June 30 was 368 million euros, compared with 344 million euros a year earlier. Looking ahead, the company continues to expect constant-currency revenue growth of 10% to 14% in 2026. Medacta also reaffirmed its target for a constant-currency revenue compound annual growth rate of 12% to 15% over the 2024 to 2027 period. Medacta will release its first-half financial results on Sept. 9.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.